CENP-T Activators

Taxol and Vinblastine directly engage with the cytoskeletal structures that are central to chromosome segregation, a process to which CENP-T is fundamental. Paclitaxel solidifies the microtubule network, enhancing the mitotic checkpoint's response, whereas Vinblastine disrupts microtubule formation, challenging CENP-T's role in maintaining genomic stability during cell division. Compounds such as Nocodazole further emphasize this theme by promoting microtubule depolymerization, activating spindle assembly checkpoints that indirectly necessitate CENP-T function for resolution. Similarly, agents like Roscovitine, which inhibits cyclin-dependent kinases, and Plk1 inhibitors like BI 2536 impede the progression of the cell cycle, indirectly necessitating CENP-T's role in chromosomal dynamics.

Other chemicals such as Monastrol and S-Trityl-L-cysteine specifically target kinesin motor proteins, disrupting spindle mechanics and thus implicating CENP-T in the ensuing checkpoint activation and mitotic arrest. Proteasome inhibitors like MG132 lead to the accumulation of regulatory proteins that could affect the stability and function of CENP-T as the cell attempts to navigate through the disrupted cell cycle. Inhibitors targeting Aurora kinases, such as ZM447439 and Tozasertib, impede the proper alignment and segregation of chromosomes, implicating CENP-T indirectly as the cell responds to these perturbations. Epigenetic modifiers like 5-Azacytidine and Trichostatin A shift the expression patterns of numerous genes, including those that may regulate or affect CENP-T, thus influencing its role in chromosomal stability through changes in the transcriptional landscape.